Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure.
Li, Ping
Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure. [electronic resource] - Acta pharmacologica Sinica May 2012 - 644-51 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1745-7254
10.1038/aps.2012.2 doi
Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
Biomarkers--blood
Biphenyl Compounds--pharmacology
Blood Pressure--drug effects
Blotting, Western
Body Weight--drug effects
Creatinine--blood
Disease Models, Animal
Fibrosis
Glycosaminoglycans--pharmacology
Immunohistochemistry
Irbesartan
Kidney--drug effects
Kidney Failure, Chronic--blood
Male
Nephrectomy--methods
Nitric Oxide Synthase Type III--genetics
Proteinuria--drug therapy
RNA, Messenger--metabolism
Rats
Rats, Wistar
Reverse Transcriptase Polymerase Chain Reaction
Sclerosis
Tetrazoles--pharmacology
Time Factors
Tissue Plasminogen Activator--genetics
Triglycerides--blood
Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure. [electronic resource] - Acta pharmacologica Sinica May 2012 - 644-51 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1745-7254
10.1038/aps.2012.2 doi
Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
Biomarkers--blood
Biphenyl Compounds--pharmacology
Blood Pressure--drug effects
Blotting, Western
Body Weight--drug effects
Creatinine--blood
Disease Models, Animal
Fibrosis
Glycosaminoglycans--pharmacology
Immunohistochemistry
Irbesartan
Kidney--drug effects
Kidney Failure, Chronic--blood
Male
Nephrectomy--methods
Nitric Oxide Synthase Type III--genetics
Proteinuria--drug therapy
RNA, Messenger--metabolism
Rats
Rats, Wistar
Reverse Transcriptase Polymerase Chain Reaction
Sclerosis
Tetrazoles--pharmacology
Time Factors
Tissue Plasminogen Activator--genetics
Triglycerides--blood